September 5, 2008 - RaQualia Pharma, Inc. will use Miner3D as its main R&D data analytics platform.


RaQualia, a pharmaceutical research and development company, is a spin off of drug maker giant Pfizer. The company focuses on pain and gastrointestinal therapeutic areas and manages six innovative drug discovery programs.


Miner3D helps RaQualia’s scientists and researchers to better understand vast amounts of scientific data, improve leads identification and speed up research and development processes.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access